A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry
Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major differences in expression from in vivo measurements of neurofilament isoforms, from the light chain, NfL (68 kDa), compared with larger proteins,...
Saved in:
Published in | Journal of neurochemistry Vol. 146; no. 5; pp. 631 - 641 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.09.2018
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0022-3042 1471-4159 1471-4159 |
DOI | 10.1111/jnc.14542 |
Cover
Loading…
Abstract | Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major differences in expression from in vivo measurements of neurofilament isoforms, from the light chain, NfL (68 kDa), compared with larger proteins, the medium chain (NfM, 150 kDa) and the heavy (NfH, 200‐210 kDa) chains in ALS patients and healthy controls. New immunological methods were combined with Nf subunit stoichiometry calculations and Monte Carlo simulations of a coarse‐grained Nf brush model. Based on a physiological Nf subunit stoichiometry of 7 : 3 : 2 (NfL:NfM:NfH), we found an ‘adaptive’ Nf subunit stoichiometry of 24 : 2.4 : 1.6 in ALS. Adaptive Nf stoichiometry preserved NfL gyration radius in the Nf brush model. The energy and time requirements for Nf translation were 56 ± 27k ATP (5.6 h) in control subjects compared to 123 ± 102k (12.3 h) in ALS with ‘adaptive’ (24:2.4:1.6) Nf stoichiometry (not significant) and increased significantly to 355 ± 330k (35.5 h) with ‘luxury’ (7:3:2) Nf subunit stoichiometry (p < 0.0001 for each comparison). Longitudinal disease progression‐related energy consumption was highest with a ‘luxury’ (7:3:2) Nf stoichiometry. Therefore, an energy and time‐saving option for motor neurons is to shift protein expression from larger to smaller (cheaper) subunits, at little or no costs on a protein structural level, to compensate for increased energy demands.
This study describes a novel concept, adaptive protein stoichiometry, which provides neurons with an efficient strategy to slow neurodegeneration. The data supporting this conclusion come from protein concentrations measured in patients suffering from a rapid neurodegenerative condition, amyotrophic lateral sclerosis (synonymous motor neuron disease, Lou Gehrig disease). Extrapolation to a much boarder disease spectrum is conceivable as ‘adaptive protein stoichiometry’ is based on the fundamental principle of ATP and time requirements for transcription. The results of present data on the neurofilament triplet protein should be applicable to other heteropolymers and offer a new conceptional framework for developing antisense therapies. |
---|---|
AbstractList | Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major differences in expression from in vivo measurements of neurofilament isoforms, from the light chain, NfL (68 kDa), compared with larger proteins, the medium chain (NfM, 150 kDa) and the heavy (NfH, 200‐210 kDa) chains in ALS patients and healthy controls. New immunological methods were combined with Nf subunit stoichiometry calculations and Monte Carlo simulations of a coarse‐grained Nf brush model. Based on a physiological Nf subunit stoichiometry of 7 : 3 : 2 (NfL:NfM:NfH), we found an ‘adaptive’ Nf subunit stoichiometry of 24 : 2.4 : 1.6 in ALS. Adaptive Nf stoichiometry preserved NfL gyration radius in the Nf brush model. The energy and time requirements for Nf translation were 56 ± 27k ATP (5.6 h) in control subjects compared to 123 ± 102k (12.3 h) in ALS with ‘adaptive’ (24:2.4:1.6) Nf stoichiometry (not significant) and increased significantly to 355 ± 330k (35.5 h) with ‘luxury’ (7:3:2) Nf subunit stoichiometry (p < 0.0001 for each comparison). Longitudinal disease progression‐related energy consumption was highest with a ‘luxury’ (7:3:2) Nf stoichiometry. Therefore, an energy and time‐saving option for motor neurons is to shift protein expression from larger to smaller (cheaper) subunits, at little or no costs on a protein structural level, to compensate for increased energy demands. Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major differences in expression from in vivo measurements of neurofilament isoforms, from the light chain, NfL (68 kDa), compared with larger proteins, the medium chain (NfM, 150 kDa) and the heavy (NfH, 200-210 kDa) chains in ALS patients and healthy controls. New immunological methods were combined with Nf subunit stoichiometry calculations and Monte Carlo simulations of a coarse-grained Nf brush model. Based on a physiological Nf subunit stoichiometry of 7 : 3 : 2 (NfL:NfM:NfH), we found an 'adaptive' Nf subunit stoichiometry of 24 : 2.4 : 1.6 in ALS. Adaptive Nf stoichiometry preserved NfL gyration radius in the Nf brush model. The energy and time requirements for Nf translation were 56 ± 27k ATP (5.6 h) in control subjects compared to 123 ± 102k (12.3 h) in ALS with 'adaptive' (24:2.4:1.6) Nf stoichiometry (not significant) and increased significantly to 355 ± 330k (35.5 h) with 'luxury' (7:3:2) Nf subunit stoichiometry (p < 0.0001 for each comparison). Longitudinal disease progression-related energy consumption was highest with a 'luxury' (7:3:2) Nf stoichiometry. Therefore, an energy and time-saving option for motor neurons is to shift protein expression from larger to smaller (cheaper) subunits, at little or no costs on a protein structural level, to compensate for increased energy demands. Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major differences in expression from in vivo measurements of neurofilament isoforms, from the light chain, NfL (68 kDa), compared with larger proteins, the medium chain (NfM, 150 kDa) and the heavy (NfH, 200-210 kDa) chains in ALS patients and healthy controls. New immunological methods were combined with Nf subunit stoichiometry calculations and Monte Carlo simulations of a coarse-grained Nf brush model. Based on a physiological Nf subunit stoichiometry of 7 : 3 : 2 (NfL:NfM:NfH), we found an 'adaptive' Nf subunit stoichiometry of 24 : 2.4 : 1.6 in ALS. Adaptive Nf stoichiometry preserved NfL gyration radius in the Nf brush model. The energy and time requirements for Nf translation were 56 ± 27k ATP (5.6 h) in control subjects compared to 123 ± 102k (12.3 h) in ALS with 'adaptive' (24:2.4:1.6) Nf stoichiometry (not significant) and increased significantly to 355 ± 330k (35.5 h) with 'luxury' (7:3:2) Nf subunit stoichiometry (p < 0.0001 for each comparison). Longitudinal disease progression-related energy consumption was highest with a 'luxury' (7:3:2) Nf stoichiometry. Therefore, an energy and time-saving option for motor neurons is to shift protein expression from larger to smaller (cheaper) subunits, at little or no costs on a protein structural level, to compensate for increased energy demands.Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major differences in expression from in vivo measurements of neurofilament isoforms, from the light chain, NfL (68 kDa), compared with larger proteins, the medium chain (NfM, 150 kDa) and the heavy (NfH, 200-210 kDa) chains in ALS patients and healthy controls. New immunological methods were combined with Nf subunit stoichiometry calculations and Monte Carlo simulations of a coarse-grained Nf brush model. Based on a physiological Nf subunit stoichiometry of 7 : 3 : 2 (NfL:NfM:NfH), we found an 'adaptive' Nf subunit stoichiometry of 24 : 2.4 : 1.6 in ALS. Adaptive Nf stoichiometry preserved NfL gyration radius in the Nf brush model. The energy and time requirements for Nf translation were 56 ± 27k ATP (5.6 h) in control subjects compared to 123 ± 102k (12.3 h) in ALS with 'adaptive' (24:2.4:1.6) Nf stoichiometry (not significant) and increased significantly to 355 ± 330k (35.5 h) with 'luxury' (7:3:2) Nf subunit stoichiometry (p < 0.0001 for each comparison). Longitudinal disease progression-related energy consumption was highest with a 'luxury' (7:3:2) Nf stoichiometry. Therefore, an energy and time-saving option for motor neurons is to shift protein expression from larger to smaller (cheaper) subunits, at little or no costs on a protein structural level, to compensate for increased energy demands. Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major differences in expression from in vivo measurements of neurofilament isoforms, from the light chain, NfL (68 kDa), compared with larger proteins, the medium chain (NfM, 150 kDa) and the heavy (NfH, 200‐210 kDa) chains in ALS patients and healthy controls. New immunological methods were combined with Nf subunit stoichiometry calculations and Monte Carlo simulations of a coarse‐grained Nf brush model. Based on a physiological Nf subunit stoichiometry of 7 : 3 : 2 (NfL:NfM:NfH), we found an ‘adaptive’ Nf subunit stoichiometry of 24 : 2.4 : 1.6 in ALS. Adaptive Nf stoichiometry preserved NfL gyration radius in the Nf brush model. The energy and time requirements for Nf translation were 56 ± 27k ATP (5.6 h) in control subjects compared to 123 ± 102k (12.3 h) in ALS with ‘adaptive’ (24:2.4:1.6) Nf stoichiometry (not significant) and increased significantly to 355 ± 330k (35.5 h) with ‘luxury’ (7:3:2) Nf subunit stoichiometry (p < 0.0001 for each comparison). Longitudinal disease progression‐related energy consumption was highest with a ‘luxury’ (7:3:2) Nf stoichiometry. Therefore, an energy and time‐saving option for motor neurons is to shift protein expression from larger to smaller (cheaper) subunits, at little or no costs on a protein structural level, to compensate for increased energy demands. This study describes a novel concept, adaptive protein stoichiometry, which provides neurons with an efficient strategy to slow neurodegeneration. The data supporting this conclusion come from protein concentrations measured in patients suffering from a rapid neurodegenerative condition, amyotrophic lateral sclerosis (synonymous motor neuron disease, Lou Gehrig disease). Extrapolation to a much boarder disease spectrum is conceivable as ‘adaptive protein stoichiometry’ is based on the fundamental principle of ATP and time requirements for transcription. The results of present data on the neurofilament triplet protein should be applicable to other heteropolymers and offer a new conceptional framework for developing antisense therapies. |
Author | Chang, Rakwoo Adiutori, Rocco Petzold, Axel Malaspina, Andrea Ceroni, Mauro Zucchi, Elisabetta Greensmith, Linda Lu, Ching‐Hua Cho, Yunju Zubiri, Irene Cereda, Cristina Pansarasa, Orietta |
AuthorAffiliation | 3 Department of Neurology China Medical University Hospital Taichung City Taiwan 11 Amsterdam UMC Departments of Neurology and Ophthalmology De Boelelaan Amsterdam NL 1 Centre for Neuroscience and Trauma Blizard Institute, Barts and the London School of Medicine and Dentistry Queen Mary University of London London UK 10 Moorfields Eye Hospital London UK 5 Department of Brain and Behavioural Sciences University of Pavia Pavia Italy 4 Department of Chemistry Kwangwoon University Seoul Korea 2 Center of Genomic and post‐Genomic IRCCS Mondino Foundation Pavia Italy 8 Department of Neuromuscular Diseases MRC Centre for Neuromuscular Diseases Queen Square London UK 9 The National Hospital for Neurology and Neurosurgery Queen Square London UK 6 General Neurology Unit IRCCS Mondino Foundation Pavia Italy 7 Sobell Department of Motor Neuroscience and Movement Disorders MRC Centre for Neuromuscular Diseases UCL Institute of Neurology University College London London UK |
AuthorAffiliation_xml | – name: 1 Centre for Neuroscience and Trauma Blizard Institute, Barts and the London School of Medicine and Dentistry Queen Mary University of London London UK – name: 2 Center of Genomic and post‐Genomic IRCCS Mondino Foundation Pavia Italy – name: 4 Department of Chemistry Kwangwoon University Seoul Korea – name: 9 The National Hospital for Neurology and Neurosurgery Queen Square London UK – name: 3 Department of Neurology China Medical University Hospital Taichung City Taiwan – name: 5 Department of Brain and Behavioural Sciences University of Pavia Pavia Italy – name: 7 Sobell Department of Motor Neuroscience and Movement Disorders MRC Centre for Neuromuscular Diseases UCL Institute of Neurology University College London London UK – name: 8 Department of Neuromuscular Diseases MRC Centre for Neuromuscular Diseases Queen Square London UK – name: 6 General Neurology Unit IRCCS Mondino Foundation Pavia Italy – name: 10 Moorfields Eye Hospital London UK – name: 11 Amsterdam UMC Departments of Neurology and Ophthalmology De Boelelaan Amsterdam NL |
Author_xml | – sequence: 1 givenname: Elisabetta surname: Zucchi fullname: Zucchi, Elisabetta organization: IRCCS Mondino Foundation – sequence: 2 givenname: Ching‐Hua surname: Lu fullname: Lu, Ching‐Hua organization: China Medical University Hospital – sequence: 3 givenname: Yunju surname: Cho fullname: Cho, Yunju organization: Kwangwoon University – sequence: 4 givenname: Rakwoo surname: Chang fullname: Chang, Rakwoo organization: Kwangwoon University – sequence: 5 givenname: Rocco surname: Adiutori fullname: Adiutori, Rocco organization: Queen Mary University of London – sequence: 6 givenname: Irene surname: Zubiri fullname: Zubiri, Irene organization: Queen Mary University of London – sequence: 7 givenname: Mauro surname: Ceroni fullname: Ceroni, Mauro organization: IRCCS Mondino Foundation – sequence: 8 givenname: Cristina surname: Cereda fullname: Cereda, Cristina organization: IRCCS Mondino Foundation – sequence: 9 givenname: Orietta surname: Pansarasa fullname: Pansarasa, Orietta organization: IRCCS Mondino Foundation – sequence: 10 givenname: Linda surname: Greensmith fullname: Greensmith, Linda organization: University College London – sequence: 11 givenname: Andrea surname: Malaspina fullname: Malaspina, Andrea organization: Queen Mary University of London – sequence: 12 givenname: Axel orcidid: 0000-0002-0344-9749 surname: Petzold fullname: Petzold, Axel email: a.petzold@ucl.ac.uk organization: De Boelelaan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29959860$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtv1DAUhS3Uik4LC_4AssQGFmn9ihOzQKpGvKoKNrC2HOdm6lFiD7bTav59PZ0pggq8sXT93eNz7zlFRz54QOgVJee0nIu1t-dU1II9QwsqGloJWqsjtCCEsYoTwU7QaUprQqgUkj5HJ0ypWrWSLFB_iaeQQ8Qe5hg8TjmaDKstzgEncws4uwmw8T0GD7HUnd-jPax2FZNd8O-x6c0mu4JvYsjgdjrB2RsXJshx-wIdD2ZM8PJwn6Gfnz7-WH6prr9__rq8vK6sEJxVnbSC14McDGnaoTOdaQSwVtleMtsp0ytBasJrxWxj1UClMR03g2Bd3XJWAz9DH_a6m7mboLfgyzSj3kQ3mbjVwTj994t3N3oVbrWkTS04KQJvDwIx_JohZT25ZGEcjYcwJ82IZLuvJC3omyfoOszRl_E0o7QsXnHeFur1n45-W3kMoAAXe8DGkFKEQVuXH5ZaDLpRU6J3EesSsX6IuHS8e9LxKPov9qB-50bY_h_UV9-W-4577O63YQ |
CitedBy_id | crossref_primary_10_1093_brain_awab382 crossref_primary_10_17116_jnevro2019119107 crossref_primary_10_1002_acn3_51428 crossref_primary_10_1080_21678421_2019_1646769 crossref_primary_10_3390_ijms252111661 crossref_primary_10_1038_s41582_018_0058_z crossref_primary_10_1038_s41582_023_00891_2 crossref_primary_10_3389_fnins_2021_689938 crossref_primary_10_1002_acn3_51234 crossref_primary_10_1038_s41582_024_00955_x crossref_primary_10_1111_jnc_15682 crossref_primary_10_1007_s12035_019_01698_3 crossref_primary_10_3390_genes15040496 crossref_primary_10_1111_ene_16192 crossref_primary_10_1111_jnc_16261 crossref_primary_10_1080_21678421_2024_2428930 crossref_primary_10_1038_s41598_022_18942_x crossref_primary_10_1002_ana_26265 crossref_primary_10_1167_tvst_13_9_30 crossref_primary_10_17116_jnevro20191191027 crossref_primary_10_1111_ane_13698 crossref_primary_10_1186_s13024_020_00406_3 |
Cites_doi | 10.1016/j.neuron.2016.05.018 10.1136/jnnp-2014-308946 10.1177/1352458510364196 10.1001/jamaneurol.2016.5398 10.1016/j.jmb.2009.06.045 10.1002/ana.20736 10.1136/jnnp-2012-303768 10.1212/01.wnl.0000203120.85850.54 10.1016/j.clinbiochem.2009.03.020 10.1016/j.cell.2004.08.026 10.1038/nrn752 10.1002/ana.24980 10.1016/S1359-0294(03)00010-4 10.1002/ana.24552 10.1152/physrev.1997.77.3.731 10.1371/journal.pone.0040998 10.1074/jbc.M115.700385 10.1080/21678421.2016.1241279 10.1016/S1474-4422(13)70233-3 10.1073/pnas.95.16.9626 10.1529/biophysj.106.095323 10.1212/WNL.0000000000004761 10.1038/nrdp.2017.71 10.1136/jnnp-2013-305494 10.1016/S1474-4422(16)00070-3 10.3109/17482968.2011.627589 10.1016/j.neurobiolaging.2018.02.017 10.1038/nrneurol.2011.151 10.3389/fnagi.2016.00290 10.1016/j.jns.2008.12.037 10.1038/nmat2566 10.3389/fncel.2015.00248 10.1038/nature12481 10.1529/biophysj.107.104695 10.1159/000101843 10.1093/brain/awq360 10.1016/S0079-6603(08)60823-5 10.1007/s12035-008-8033-0 10.1016/S1093-3263(00)00138-8 10.1016/j.jim.2009.09.014 10.1038/nrneurol.2014.228 10.1038/nrneurol.2014.37 10.1002/ana.22438 10.1016/S0006-3495(02)75581-1 10.1515/cclm-2015-1195 10.1371/journal.pone.0075091 10.1042/BST20120101 10.1111/j.1471-4159.1987.tb01002.x 10.1111/j.1471-4159.1985.tb05442.x 10.1136/jnnp.2005.085175 10.1016/j.jns.2011.04.023 10.4155/bio-2016-0114 10.1016/S0962-8924(97)01049-0 10.1016/j.jns.2005.03.015 10.1212/WNL.0000000000001642 10.1007/s00415-017-8730-6 10.1007/BF00966828 10.1136/jnnp-2017-316605 10.1093/brain/awp046 10.1016/S0092-8674(01)00244-6 10.1038/msb.2009.68 10.1212/WNL.0b013e3181c47cc2 10.1038/375061a0 10.1016/0092-8674(92)90183-D 10.1016/j.jneumeth.2010.11.026 10.1126/science.aac4354 10.1136/jnnp-2014-309827 10.1016/j.brainresbull.2016.09.002 10.1212/WNL.0000000000004029 10.1111/j.1471-4159.2011.07224.x 10.1016/j.nbd.2017.04.007 10.1016/j.jmb.2010.11.022 10.1080/14656566.2016.1202919 10.1002/ana.25143 |
ContentType | Journal Article |
Copyright | 2018 The Authors. published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry 2018 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. Copyright © 2018 International Society for Neurochemistry |
Copyright_xml | – notice: 2018 The Authors. published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry – notice: 2018 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. – notice: Copyright © 2018 International Society for Neurochemistry |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
DOI | 10.1111/jnc.14542 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
DocumentTitleAlternate | E. Zucchi et al |
EISSN | 1471-4159 |
EndPage | 641 |
ExternalDocumentID | PMC6175430 29959860 10_1111_jnc_14542 JNC14542 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Research Foundation of Korea funderid: 2015R1D1A1A01058045 – fundername: National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust – fundername: UK MND Association – fundername: UCL Institute of Ophthalmology – fundername: Korea Institute of Science and Technology Information funderid: KSC‐2017‐C3‐0003 – fundername: Motor Neurone Disease Association grantid: MALASPINA/APR13/817-791 – fundername: Motor Neurone Disease Association grantid: TURNER/OCT15/972-797 – fundername: Korea Institute of Science and Technology Information grantid: KSC‐2017‐C3‐0003 – fundername: National Research Foundation of Korea grantid: 2015R1D1A1A01058045 |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYJJ AAZKR ABCQN ABCUV ABEML ABIVO ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HGLYW HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
ID | FETCH-LOGICAL-c4432-b6c435f6fa078fbaba74e289cd62cb9ad940503592c7c9f16aab3af42b58325e3 |
IEDL.DBID | DR2 |
ISSN | 0022-3042 1471-4159 |
IngestDate | Thu Aug 21 18:04:53 EDT 2025 Thu Jul 10 17:56:11 EDT 2025 Fri Jul 25 19:42:23 EDT 2025 Mon Jul 21 06:03:20 EDT 2025 Thu Apr 24 23:06:17 EDT 2025 Tue Jul 01 04:39:23 EDT 2025 Wed Jan 22 16:44:45 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | ALS neurodegeneration stoichiometry neurofilaments energy |
Language | English |
License | Attribution 2018 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4432-b6c435f6fa078fbaba74e289cd62cb9ad940503592c7c9f16aab3af42b58325e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. |
ORCID | 0000-0002-0344-9749 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.14542 |
PMID | 29959860 |
PQID | 2110229338 |
PQPubID | 31528 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6175430 proquest_miscellaneous_2062832561 proquest_journals_2110229338 pubmed_primary_29959860 crossref_citationtrail_10_1111_jnc_14542 crossref_primary_10_1111_jnc_14542 wiley_primary_10_1111_jnc_14542_JNC14542 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2018 2018-09-00 20180901 |
PublicationDateYYYYMMDD | 2018-09-01 |
PublicationDate_xml | – month: 09 year: 2018 text: September 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York – name: Hoboken |
PublicationTitle | Journal of neurochemistry |
PublicationTitleAlternate | J Neurochem |
PublicationYear | 2018 |
Publisher | Blackwell Publishing Ltd John Wiley and Sons Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: John Wiley and Sons Inc |
References | 2010; 16 2017; 82 2017; 3 2009; 42 2011; 117 2017; 88 2008; 38 1992; 17 2000; 1 2018; 83 1995; 375 2018; 89 2013; 8 2011; 195 2012; 13 2001; 104 2009; 279 2016; 79 1997; 7 2017; 74 2011; 405 2015; 84 2006; 66 2015; 86 2003; 8 2015; 87 2001; 19 2010; 352 2016; 87 2016; 353 2014; 13 2007; 4 2011; 69 1998; 95 2010; 9 2014; 10 1987; 49 2007b; 93 2018; 265 2005; 233 2013; 84 2013; 501 2015; 11 2006; 59 2016; 54 2009; 132 2002; 3 2002; 82 1998; 61 2016; 126 2007a; 93 2016; 91 2014; 85 1985; 44 2018; 67 2016; 17 2015; 9 2016; 15 2006a; 77 2011; 134 2011; 7 2011; 307 2009; 73 1997; 77 2009; 391 2018; 90 1992; 68 2016 2017; 18 2009; 5 2012; 7 2016; 291 2004; 118 2017; 104 2016; 8 2012; 40 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_68_1 e_1_2_8_3_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_66_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_62_1 e_1_2_8_41_1 e_1_2_8_60_1 e_1_2_8_17_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_59_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_57_1 e_1_2_8_70_1 Disanto G. (e_1_2_8_19_1) 2015; 87 e_1_2_8_32_1 e_1_2_8_55_1 e_1_2_8_78_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_76_1 e_1_2_8_51_1 e_1_2_8_74_1 e_1_2_8_30_1 e_1_2_8_72_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 Steinacker P. (e_1_2_8_64_1) 2016; 87 e_1_2_8_69_1 Brooks B. R. (e_1_2_8_11_1) 2000; 1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_67_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_65_1 e_1_2_8_63_1 e_1_2_8_40_1 e_1_2_8_61_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_58_1 e_1_2_8_79_1 Zetterberg H. (e_1_2_8_77_1) 2016 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_56_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_54_1 e_1_2_8_75_1 e_1_2_8_52_1 e_1_2_8_73_1 e_1_2_8_50_1 e_1_2_8_71_1 |
References_xml | – volume: 61 start-page: 1 year: 1998 end-page: 23 article-title: Neurofilaments in health and disease publication-title: Prog. Nucleic Acid Res. Mol. Biol. – volume: 233 start-page: 183 year: 2005 end-page: 198 article-title: Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss publication-title: J. Neurol. Sci. – volume: 265 start-page: 510 year: 2018 end-page: 521 article-title: CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis publication-title: J. Neurol. – volume: 11 start-page: 11 year: 2015 end-page: 24 article-title: Disturbed mitochondrial dynamics and neurodegenerative disorders publication-title: Nat. Rev. Neurol. – volume: 17 start-page: 1005 year: 1992 end-page: 1009 article-title: Proteolysis of filament proteins in glial and neuronal cells after in vivo stimulation of hippocampal NMDA receptors publication-title: Neurochem. Res. – volume: 3 start-page: 17071 year: 2017 article-title: Amyotrophic lateral sclerosis publication-title: Nat. Rev. Dis. Prim. – volume: 7 start-page: 243 year: 1997 end-page: 249 article-title: Neurofilaments and motor neuron disease publication-title: Trends Cell Biol. – volume: 279 start-page: 76 year: 2009 end-page: 79 article-title: Longitudinal one‐year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy publication-title: J. Neurol. Sci. – volume: 38 start-page: 27 year: 2008 end-page: 65 article-title: Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration publication-title: Mol. Neurobiol. – volume: 501 start-page: 45 year: 2013 end-page: 51 article-title: Self‐propagation of pathogenic protein aggregates in neurodegenerative diseases publication-title: Nature – year: 2016 article-title: Neurological Biomarkers publication-title: Rev. Cell Biol. Mol. Med. – volume: 10 start-page: 225 year: 2014 end-page: 238 article-title: Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis publication-title: Nat. Rev. Neurol. – volume: 13 start-page: 1 year: 2012 end-page: 10 article-title: Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS publication-title: Amyotroph Lateral Scler. – volume: 86 start-page: 1388 year: 2015 end-page: 1390 article-title: The prognostic value of CSF neurofilaments in multiple sclerosis at 15‐year follow‐up publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 307 start-page: 132 year: 2011 end-page: 138 article-title: Neurofilament stoichiometry simulations during neurodegeneration suggest a remarkable self‐sufficient and stable in vivo protein structure publication-title: J. Neurol. Sci. – volume: 68 start-page: 451 year: 1992 end-page: 463 article-title: Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells publication-title: Cell – volume: 13 start-page: 113 year: 2014 end-page: 126 article-title: Body fluid biomarkers in multiple sclerosis publication-title: Lancet. Neurol. – volume: 117 start-page: 528 year: 2011 end-page: 537 article-title: Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS publication-title: J. Neurochem. – volume: 8 start-page: e75091 year: 2013 article-title: Increased neurofilament light chain blood levels in neurodegenerative neurological diseases publication-title: PLoS ONE – volume: 405 start-page: 1101 year: 2011 end-page: 1118 article-title: Phosphorylation‐mediated conformational changes in the mouse neurofilament architecture: insight from a neurofilament brush model publication-title: J. Mol. Biol. – volume: 85 start-page: 274 year: 2014 end-page: 278 article-title: Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 104 start-page: 581 year: 2001 end-page: 591 article-title: Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded publication-title: Cell – volume: 9 start-page: 248 year: 2015 article-title: Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice publication-title: Front. Cell. Neurosci. – volume: 8 start-page: 40 year: 2003 end-page: 47 article-title: Assembly and structure of neurofilaments publication-title: Curr. Opin. Colloid Interface Sci. – volume: 17 start-page: 1669 year: 2016 end-page: 1682 article-title: Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection publication-title: Expert Opin. Pharmacother. – volume: 15 start-page: 673 year: 2016 end-page: 684 article-title: CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta‐analysis publication-title: Lancet Neurol. – volume: 88 start-page: 2302 year: 2017 end-page: 2309 article-title: Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease publication-title: Neurology – volume: 66 start-page: 852 year: 2006 end-page: 856 article-title: Axonal damage markers in cerebrospinal fluid are increased in ALS publication-title: Neurology – volume: 19 start-page: 26 year: 2001 end-page: 59 article-title: Intrinsically disordered protein publication-title: J. Mol. Graph. Model. – volume: 74 start-page: 525 year: 2017 end-page: 532 article-title: Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease publication-title: JAMA Neurol. – volume: 7 start-page: e40998 year: 2012 article-title: Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS publication-title: PLoS ONE – volume: 77 start-page: 731 year: 1997 end-page: 758 article-title: Cellular energy utilization and molecular origin of standard metabolic rate in mammals publication-title: Physiol. Rev. – volume: 8 start-page: 290 year: 2016 article-title: Neurofilaments in CSF as diagnostic biomarkers in motor neuron disease: a meta‐analysis publication-title: Front. Aging Neurosci. – volume: 4 start-page: 185 year: 2007 end-page: 194 article-title: A systematic review and meta‐analysis of CSF neurofilament protein levels as biomarkers in dementia publication-title: Neurodegener. Dis. – volume: 353 start-page: aac4354 year: 2016 article-title: In vivo aspects of protein folding and quality control publication-title: Science – volume: 352 start-page: 23 year: 2010 end-page: 31 article-title: Neurofilament ELISA validation publication-title: J. Immunol. Methods – volume: 69 start-page: 1065‐6‐7 year: 2011 article-title: The neurofilament light chain is not stable in vitro publication-title: Ann. Neurol. – volume: 89 start-page: 367 year: 2018 end-page: 373 article-title: Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 59 start-page: 478 year: 2006 end-page: 489 article-title: Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients publication-title: Ann. Neurol. – volume: 90 start-page: e22 year: 2018 end-page: e30 article-title: Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis publication-title: Neurology – volume: 16 start-page: 549 year: 2010 end-page: 554 article-title: Cerebrospinal fluid ATP metabolites in multiple sclerosis publication-title: Mult. Scler. – volume: 86 start-page: 667 year: 2015 end-page: 673 article-title: Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 67 start-page: 21 year: 2018 end-page: 22 article-title: Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis publication-title: Neurobiol. Aging – volume: 291 start-page: 4356 year: 2016 end-page: 4373 article-title: Selective inhibition of the mitochondrial permeability transition pore protects against neurodegeneration in experimental multiple sclerosis publication-title: J. Biol. Chem. – volume: 83 start-page: 258 year: 2018 end-page: 268 article-title: Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis publication-title: Ann. Neurol. – volume: 132 start-page: 1161 year: 2009 end-page: 1174 article-title: Mitochondrial changes within axons in multiple sclerosis publication-title: Brain – volume: 84 start-page: 2247 year: 2015 end-page: 2257 article-title: Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis publication-title: Neurology – volume: 40 start-page: 1027 year: 2012 end-page: 1031 article-title: Structures and interactions in “bottlebrush” neurofilaments: the role of charged disordered proteins in forming hydrogel networks publication-title: Biochem. Soc. Trans. – volume: 82 start-page: 2360 year: 2002 end-page: 2372 article-title: Relating interactions between neurofilaments to the structure of axonal neurofilament distributions through polymer brush models publication-title: Biophys. J . – volume: 93 start-page: 1421 year: 2007a end-page: 30 article-title: A self‐consistent field analysis of the neurofilament brush with amino‐acid resolution publication-title: Biophys. J . – volume: 79 start-page: 152 year: 2016 end-page: 158 article-title: Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis publication-title: Ann. Neurol. – volume: 134 start-page: 464 year: 2011 end-page: 483 article-title: In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study publication-title: Brain – volume: 87 start-page: 126 year: 2015 end-page: 129 article-title: Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 91 start-page: 56 year: 2016 end-page: 66 article-title: Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases publication-title: Neuron – volume: 375 start-page: 61 year: 1995 end-page: 64 article-title: Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis publication-title: Nature – volume: 95 start-page: 9626 year: 1998 end-page: 30 article-title: Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase publication-title: Proc. Natl Acad. Sci. USA – volume: 54 start-page: 1655 year: 2016 end-page: 1661 article-title: Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa publication-title: Clin. Chem. Lab. Med. – volume: 87 start-page: 12 year: 2016 end-page: 20 article-title: Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients publication-title: J. Neurol. Neurosurg. – volume: 84 start-page: 467 year: 2013 end-page: 472 article-title: Phosphorylated neurofilament heavy subunit (pNF‐H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 195 start-page: 143 year: 2011 end-page: 150 article-title: A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament hook effect publication-title: J. Neurosci. Methods – volume: 126 start-page: 334 year: 2016 end-page: 346 article-title: Specialized roles of neurofilament proteins in synapses: relevance to neuropsychiatric disorders publication-title: Brain Res. Bull. – volume: 42 start-page: 1001 year: 2009 end-page: 1006 article-title: Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients publication-title: Clin. Biochem. – volume: 44 start-page: 502 year: 1985 end-page: 509 article-title: An immunoblot study of neurofilament degradation in situ and during calcium‐activated proteolysis publication-title: J. Neurochem. – volume: 18 start-page: 112 year: 2017 end-page: 119 article-title: Diagnostic and prognostic significance of neurofilament light chain NF‐L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: data from the German MND‐net publication-title: Amyotroph. Lateral Scler. Frontotemporal Degener. – volume: 7 start-page: 631 year: 2011 end-page: 638 article-title: Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations publication-title: Nat. Rev. Neurol. – volume: 8 start-page: 2243 year: 2016 end-page: 2254 article-title: Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration publication-title: Bioanalysis – volume: 93 start-page: 1452 year: 2007b end-page: 1463 article-title: Effect of the ionic strength and pH on the equilibrium structure of a neurofilament brush publication-title: Biophys. J . – volume: 5 start-page: 314 year: 2009 article-title: Ribosome and transcript copy numbers, polysome occupancy and enzyme dynamics in Arabidopsis publication-title: Mol. Syst. Biol. – volume: 3 start-page: 216 year: 2002 end-page: 227 article-title: Innate immunity: the missing link in neuroprotection and neurodegeneration? publication-title: Nat. Rev. Neurosci. – volume: 118 start-page: 687 year: 2004 end-page: 698 article-title: Neuroprotection in ischemia: blocking calcium‐permeable acid‐sensing ion channels publication-title: Cell – volume: 9 start-page: 40 year: 2010 end-page: 46 article-title: Gel‐expanded to gel‐condensed transition in neurofilament networks revealed by direct force measurements publication-title: Nat. Mater. – volume: 73 start-page: 1914 year: 2009 end-page: 1922 article-title: A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking publication-title: Neurology – volume: 1 start-page: 293 year: 2000 end-page: 299 article-title: Amyotroph Lateral Scler Other Motor Neuron Disord publication-title: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases – volume: 82 start-page: 139 year: 2017 end-page: 146 article-title: Phosphorylated neurofilament heavy chain: a biomarker of survival for ‐associated amyotrophic lateral sclerosis publication-title: Ann. Neurol. – volume: 391 start-page: 648 year: 2009 end-page: 660 article-title: Structural properties of neurofilament sidearms: sequence‐based modeling of neurofilament architecture publication-title: J. Mol. Biol. – volume: 77 start-page: 753 year: 2006a end-page: 759 article-title: Axonal damage and outcome in subarachnoid haemorrhage publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 104 start-page: 73 year: 2017 end-page: 84 article-title: NF‐L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration publication-title: Neurobiol. Dis. – volume: 49 start-page: 1375 year: 1987 end-page: 1378 article-title: A rapid HPLC method to separate the triplet proteins of neurofilament publication-title: J. Neurochem. – ident: e_1_2_8_3_1 doi: 10.1016/j.neuron.2016.05.018 – ident: e_1_2_8_69_1 doi: 10.1136/jnnp-2014-308946 – ident: e_1_2_8_40_1 doi: 10.1177/1352458510364196 – ident: e_1_2_8_24_1 doi: 10.1001/jamaneurol.2016.5398 – year: 2016 ident: e_1_2_8_77_1 article-title: Neurological Biomarkers publication-title: Rev. Cell Biol. Mol. Med. – ident: e_1_2_8_14_1 doi: 10.1016/j.jmb.2009.06.045 – ident: e_1_2_8_21_1 doi: 10.1002/ana.20736 – ident: e_1_2_8_9_1 doi: 10.1136/jnnp-2012-303768 – ident: e_1_2_8_10_1 doi: 10.1212/01.wnl.0000203120.85850.54 – ident: e_1_2_8_2_1 doi: 10.1016/j.clinbiochem.2009.03.020 – ident: e_1_2_8_75_1 doi: 10.1016/j.cell.2004.08.026 – ident: e_1_2_8_47_1 doi: 10.1038/nrn752 – ident: e_1_2_8_27_1 doi: 10.1002/ana.24980 – ident: e_1_2_8_30_1 doi: 10.1016/S1359-0294(03)00010-4 – ident: e_1_2_8_74_1 doi: 10.1002/ana.24552 – ident: e_1_2_8_61_1 doi: 10.1152/physrev.1997.77.3.731 – ident: e_1_2_8_43_1 doi: 10.1371/journal.pone.0040998 – ident: e_1_2_8_73_1 doi: 10.1074/jbc.M115.700385 – ident: e_1_2_8_65_1 doi: 10.1080/21678421.2016.1241279 – ident: e_1_2_8_16_1 doi: 10.1016/S1474-4422(13)70233-3 – ident: e_1_2_8_17_1 doi: 10.1073/pnas.95.16.9626 – ident: e_1_2_8_78_1 doi: 10.1529/biophysj.106.095323 – ident: e_1_2_8_22_1 doi: 10.1212/WNL.0000000000004761 – ident: e_1_2_8_28_1 doi: 10.1038/nrdp.2017.71 – ident: e_1_2_8_60_1 doi: 10.1136/jnnp-2013-305494 – ident: e_1_2_8_48_1 doi: 10.1016/S1474-4422(16)00070-3 – volume: 87 start-page: 12 year: 2016 ident: e_1_2_8_64_1 article-title: Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients publication-title: J. Neurol. Neurosurg. – ident: e_1_2_8_49_1 doi: 10.3109/17482968.2011.627589 – ident: e_1_2_8_70_1 doi: 10.1016/j.neurobiolaging.2018.02.017 – ident: e_1_2_8_8_1 doi: 10.1038/nrneurol.2011.151 – ident: e_1_2_8_41_1 doi: 10.3389/fnagi.2016.00290 – ident: e_1_2_8_55_1 doi: 10.1016/j.jns.2008.12.037 – volume: 87 start-page: 126 year: 2015 ident: e_1_2_8_19_1 article-title: Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome publication-title: J. Neurol. Neurosurg. Psychiatry – ident: e_1_2_8_5_1 doi: 10.1038/nmat2566 – ident: e_1_2_8_29_1 doi: 10.3389/fncel.2015.00248 – ident: e_1_2_8_31_1 doi: 10.1038/nature12481 – ident: e_1_2_8_79_1 doi: 10.1529/biophysj.107.104695 – ident: e_1_2_8_54_1 doi: 10.1159/000101843 – ident: e_1_2_8_57_1 doi: 10.1093/brain/awq360 – ident: e_1_2_8_34_1 doi: 10.1016/S0079-6603(08)60823-5 – ident: e_1_2_8_50_1 doi: 10.1007/s12035-008-8033-0 – ident: e_1_2_8_20_1 doi: 10.1016/S1093-3263(00)00138-8 – ident: e_1_2_8_56_1 doi: 10.1016/j.jim.2009.09.014 – volume: 1 start-page: 293 year: 2000 ident: e_1_2_8_11_1 article-title: Amyotroph Lateral Scler Other Motor Neuron Disord publication-title: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases – ident: e_1_2_8_13_1 doi: 10.1038/nrneurol.2014.228 – ident: e_1_2_8_23_1 doi: 10.1038/nrneurol.2014.37 – ident: e_1_2_8_37_1 doi: 10.1002/ana.22438 – ident: e_1_2_8_39_1 doi: 10.1016/S0006-3495(02)75581-1 – ident: e_1_2_8_38_1 doi: 10.1515/cclm-2015-1195 – ident: e_1_2_8_25_1 doi: 10.1371/journal.pone.0075091 – ident: e_1_2_8_6_1 doi: 10.1042/BST20120101 – ident: e_1_2_8_35_1 doi: 10.1111/j.1471-4159.1987.tb01002.x – ident: e_1_2_8_63_1 doi: 10.1111/j.1471-4159.1985.tb05442.x – ident: e_1_2_8_53_1 doi: 10.1136/jnnp.2005.085175 – ident: e_1_2_8_36_1 doi: 10.1016/j.jns.2011.04.023 – ident: e_1_2_8_46_1 doi: 10.4155/bio-2016-0114 – ident: e_1_2_8_32_1 doi: 10.1016/S0962-8924(97)01049-0 – ident: e_1_2_8_51_1 doi: 10.1016/j.jns.2005.03.015 – ident: e_1_2_8_44_1 doi: 10.1212/WNL.0000000000001642 – ident: e_1_2_8_62_1 doi: 10.1007/s00415-017-8730-6 – ident: e_1_2_8_72_1 doi: 10.1007/BF00966828 – ident: e_1_2_8_18_1 doi: 10.1136/jnnp-2017-316605 – ident: e_1_2_8_45_1 doi: 10.1093/brain/awp046 – ident: e_1_2_8_33_1 doi: 10.1016/S0092-8674(01)00244-6 – ident: e_1_2_8_58_1 doi: 10.1038/msb.2009.68 – ident: e_1_2_8_67_1 doi: 10.1212/WNL.0b013e3181c47cc2 – ident: e_1_2_8_15_1 doi: 10.1038/375061a0 – ident: e_1_2_8_71_1 doi: 10.1016/0092-8674(92)90183-D – ident: e_1_2_8_42_1 doi: 10.1016/j.jneumeth.2010.11.026 – ident: e_1_2_8_4_1 doi: 10.1126/science.aac4354 – ident: e_1_2_8_52_1 doi: 10.1136/jnnp-2014-309827 – ident: e_1_2_8_76_1 doi: 10.1016/j.brainresbull.2016.09.002 – ident: e_1_2_8_59_1 doi: 10.1212/WNL.0000000000004029 – ident: e_1_2_8_26_1 doi: 10.1111/j.1471-4159.2011.07224.x – ident: e_1_2_8_12_1 doi: 10.1016/j.nbd.2017.04.007 – ident: e_1_2_8_66_1 doi: 10.1016/j.jmb.2010.11.022 – ident: e_1_2_8_7_1 doi: 10.1080/14656566.2016.1202919 – ident: e_1_2_8_68_1 doi: 10.1002/ana.25143 |
SSID | ssj0016461 |
Score | 2.3877802 |
Snippet | Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 631 |
SubjectTerms | Adaptor Proteins, Signal Transducing - metabolism Adenosine Triphosphate - metabolism Aged ALS Amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis - blood Amyotrophic Lateral Sclerosis - pathology Biomarkers Case-Control Studies Chains Cohort Studies Computer simulation Control methods Disease Progression energy Energy conservation Energy consumption Energy Metabolism - physiology Female Humans Immunology In vivo methods and tests Isoforms Male Middle Aged Monte Carlo simulation Motor neurons Motor Neurons - physiology Motors Neurodegeneration Neurofilament Proteins - blood Neurofilament Proteins - metabolism neurofilaments Original ORIGINAL ARTICLES Protein Isoforms - blood Proteins Stoichiometry Time Factors |
Title | A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.14542 https://www.ncbi.nlm.nih.gov/pubmed/29959860 https://www.proquest.com/docview/2110229338 https://www.proquest.com/docview/2062832561 https://pubmed.ncbi.nlm.nih.gov/PMC6175430 |
Volume | 146 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3La9wwEIeHNJf20kfSh9t0UUspuTisZUleJ6dlaQg5hFIayKFg9HKzpJVDdreQ_vWdkR9kkxRKbwaPbdmekX5jjz4BfNC69uOxGadOSp2SZEgnJvdpXeBgkhlOkpyqLU7U0ak4PpNnG3DQz4Vp-RDDBzeKjNhfU4Brs7gZ5Bg_mZCC-l-q1SJB9GVARxE2KxtI4eiZHVUoVvH0R66PRXcE5t06yZv6NQ5Ah0_gW9_0tu7kYm-1NHv29y2q43_e21N43AlTNm096Rls-LAF29OASfnPa_aRxVLR-A1-Cx7O-mXitsFNGb7t5opFMmZgixZ3e82WDVvoX57R6vVMB8d8nGbI5qE1df57RF6TZ-wz7fQl9bwsgiPmdJ5mbs8JDoCXeQ6nh5--zo7SbumG1AqR89QoizqsVrVGCVIbbXQhPOZ21iluTaldKQhEI0tuC1vWmdLa5LoW3EjsYqTPX8BmaIJ_BcyWWWklF87WueCF1coWBvMsZaUX1roEdvuXWNmOa07La_yohvwm2Co-zQTeD6aXLczjPqOd3hOqLp4XFaXJHJVRPkng3bAbnzT9XtHBNyu0oemo2HiVJfCydZzhKpywbhM1TqBYc6nBgCjf63vC_DzSvlFiSpHjkbvRY_7e8Or4ZBY3Xv-76Rt4hApw0hbN7cDm8mrl36LKWpoRPODi8ygG1YjGO_kHRT8npg |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5V7aFceLQ8AgUMQqiXVJvEdjaIy2pFtZSyB9RKvaDIr7QrwKm6u5XaX98Z56EuBQlxi-Rx7Ngz9jfO-BuAd0pVbjDQg9gKoWKCDPFQZy6uctxMEp0SJKdoi6mcHPODE3GyBh-7uzANP0R_4EaWEdZrMnA6kL5t5WhACRccF-ANyugdHKpvPXkUEWclPVc46mbLKxTieLqqq7vRHYh5N1LyNoINW9D-A_jedb6JPPmxt1zoPXP9G6_j_37dQ7jfYlM2apTpEaw5vwXbI49--a8r9p6FaNFwDL8Fm-MuU9w22BHDCa8vWCDH9GzeMN5esUXN5urSMUpgz5S3zIWbhmzmG1HrTgPrNSnHB6asOqfFlwXuiBm9p56ZM-IHwGYew_H-p6PxJG6zN8SG8yyNtTQIxSpZKUQhlVZa5dyhe2esTI0ulC04cdGIIjW5KapEKqUzVfFUC1xlhMuewLqvvXsGzBRJYUTKrakynuZGSZNrdLWkEY4bYyPY7WaxNC21OWXY-Fn2Lo43ZRjNCN72oucNn8efhHY6VShbk56X5CmnCI6yYQRv-mIcafrDoryrlyhDN1Kx8zKJ4GmjOX0rKTG7DeUggnxFp3oBIvpeLfGzs0D4jShT8Axr7gaV-XvHy4PpODw8_3fR17A5Ofp6WB5-nn55AfcQEA6bGLodWF9cLN1LBF0L_SrY1g2pyCoE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3fa9RAEMeHUkF98UerNVp1FZG-pCSb3U2iT8fVo1Y5RCz0QQj7K_aw3Ry9O6H-9c5uftCzCuJbIJNkk8zsfieZ_SzAKylrmyQqiQ3nMvaSIS5UZuM6x8EkVdRLcl9tMRWHx-zohJ9swNt-LkzLhxg-uPnICP21D_C5qa8GOcZPyjjD_vcGE0nhXfrg88CO8tysdECFo2t2WKFQxtMfuj4YXVOY1wslrwrYMAJN7sLXvu1t4cn3_dVS7eufv2Ed__Pm7sGdTpmSUetK92HDui3YHjnMys8vyWsSakXDR_gtuDXu14nbBjMi-LqbCxLQmI4sWt7tJVk2ZCF_WOKXryfSGWLDPEMyc62psd8C89q7xhsijZz7rpcEcsTMn6eZ6VNPB8DLPIDjybsv48O4W7sh1oxlNFZCoxCrRS1Rg9RKKpkzi8mdNoJqVUpTMk-i4SXVuS7rVEipMlkzqjj2MdxmD2HTNc4-AqLLtNScMqPrjNFcS6FzhYmW0NwyrU0Ee_1LrHQHNvfra5xVQ4LjdBWeZgQvB9N5S_P4k9Fu7wlVF9CLyufJFKVRVkTwYtiNT9r_X5HONiu08fNRsfEijWCndZzhKtRz3QqRRJCvudRg4DHf63vc7DTgvlFjcpbhkXvBY_7e8OpoOg4bj__d9Dnc_HQwqT6-n354ArdRDRZtAd0ubC4vVvYpKq6lehYi6xc2-yi8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+motor+neuron+strategy+to+save+time+and+energy+in+neurodegeneration%3A+adaptive+protein+stoichiometry&rft.jtitle=Journal+of+neurochemistry&rft.au=Zucchi%2C+Elisabetta&rft.au=Lu%2C+Ching%E2%80%90Hua&rft.au=Cho%2C+Yunju&rft.au=Chang%2C+Rakwoo&rft.date=2018-09-01&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=146&rft.issue=5&rft.spage=631&rft.epage=641&rft_id=info:doi/10.1111%2Fjnc.14542&rft.externalDBID=10.1111%252Fjnc.14542&rft.externalDocID=JNC14542 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon |